v3.26.1
Commitments and Contingencies (Tables)
 6 Months Ended
Jun. 30, 2026
License One  
Commitments and Contingencies  
Schedule of milestone payments the company shall pay to licensor

​

​

​

​

​

Milestone Event

  ​ ​ ​

Amount

1. Enrollment of first patient in a phase II clinical trial of a therapeutic product or process

​

$

[**]

2. Enrollment of first patient in a phase III clinical trial of a therapeutic product or process

​

$

[**]

3. First commercial sale of a therapeutic product or process

​

$

[**]

4. Filing of an application for regulatory approval of a clinical diagnostic product or process

​

$

100,000

5. First regulatory approval of a clinical diagnostic product or process

​

$

150,000

6. Change of Control Liquidity Event:

​

​

​

a. between $50 million and $100 million, or

​

$

[**]

b. greater than $100 million

​

$

[**]
License Two  
Commitments and Contingencies  
Schedule of milestone payments the company shall pay to licensor

​

​

​

​

​

Milestone Event

  ​ ​ ​

Amount

1. Upon filing of a New Drug Application with the FDA for a product(s) subject to the SKI License

​

$

50,000

2. Enrollment of first patient in a phase III clinical trial of a therapeutic product or process

​

$

125,000